✦ LIBER ✦

Differences in immunoreactivity of estrogen receptor (ER) in tamoxifen-sensitive and -resistant breast carcinomas: preclinical and first clinical investigations

✍ Scribed by H. Naundorf; B. Jost-Reuhl; M. Becker; T. Reuhl; C. Neumann; I. Fichtner

Book ID: 110234361
Publisher: Springer US
Year: 2000
Tongue: English
Weight: 102 KB
Volume: 60
Category: Article
ISSN: 0167-6806
DOI: 10.1023/a:1006334131241

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

S26 The molecular biology of the estroge

S26 The molecular biology of the estrogen receptor (ER) aids in the understanding of tamoxifen resistance and breast cancer prevention with raloxifene

✍ V.C. Jordan 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 307 KB

Comparison of estrogen receptor determin

Comparison of estrogen receptor determinations by a biochemical ligand-binding assay and immunohistochemical staining with monoclonal antibody ER1D5 in females with lymph node positive breast carcinoma entered on two prospective clinical trials

✍ Steven R. Alberts; James N. Ingle; Patrick R. Roche; Stephen S. Cha; Lester E. W 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 830 KB

## BACKGROUND. The measurement of estrogen receptors (ER) in breast cancer specimens has traditionally been assessed with a tlextran-coated charcoal assay (DCCA). More recently the immunohistochemical staining (IHC) method has gained increasing popularity because of its ability to use fixed tissue